Eva Hilgenfeld

447 total citations
13 papers, 318 citations indexed

About

Eva Hilgenfeld is a scholar working on Genetics, Molecular Biology and Genetics. According to data from OpenAlex, Eva Hilgenfeld has authored 13 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Eva Hilgenfeld's work include Genomic variations and chromosomal abnormalities (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Eva Hilgenfeld is often cited by papers focused on Genomic variations and chromosomal abnormalities (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Eva Hilgenfeld collaborates with scholars based in Germany, United States and Netherlands. Eva Hilgenfeld's co-authors include Thomas Ried, Hesed Padilla‐Nash, Evelin Schröck, Kerstin Heselmeyer‐Haddad, Hongen Zhang, Merryn Macville, Nicole E. McNeil, Danny Wangsa, Β. Michael Ghadimi and Meena Augustus and has published in prestigious journals such as Cancer Research, Oncogene and European Journal of Cancer.

In The Last Decade

Eva Hilgenfeld

13 papers receiving 309 citations

Peers

Countries citing papers authored by Eva Hilgenfeld

Since Specialization

Citations

This map shows the geographic impact of Eva Hilgenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hilgenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hilgenfeld more than expected).

Fields of papers citing papers by Eva Hilgenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hilgenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hilgenfeld. The network helps show where Eva Hilgenfeld may publish in the future.

Co-authorship network of co-authors of Eva Hilgenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hilgenfeld. A scholar is included among the top collaborators of Eva Hilgenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hilgenfeld. Eva Hilgenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Transforming Growth Factor-β Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis 2004 ·Cancer Research ·Philip J. Lucas, Nicole E. McNeil, Eva Hilgenfeld, Baishakhi Choudhury, Seong Jin Kim, Michael Eckhaus, Thomas Ried, Ronald E. Gress	28
2	Spectral Karyotyping in Cancer Cytogenetics 2003 ·Humana Press eBooks ·Eva Hilgenfeld, Cristina Montagna, Hesed Padilla‐Nash, (unknown), Kerstin Heselmeyer‐Haddad, Thomas Ried	9
3	Multicolor Karyotyping in Acute Myeloid Leukemia 2003 ·Leukemia & lymphoma ·Joëlle Tchinda, (unknown), Nicole E. McNeil, Thomas Neumann, Ingo Kennerknecht, Thomas Ried, Thomas Büchner, Hubert Serve, Wolfgang E. Berdel, Jürgen Horst, Eva Hilgenfeld	13
4	Reciprocal DNA topoisomerase II cleavage events at 5′-TATTA-3′ sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing 2003 ·Oncogene ·Ryan J. Whitmarsh, (unknown), Ya Zhuo, Eva Hilgenfeld, Eric Rappaport, Maureen D. Megonigal, Martin Carroll, Mingli Liu, Neil Osheroff, Nai‐Kong V. Cheung, Diana J. Slater, Thomas Ried, Turid Knutsen, Ian A. Blair, Carolyn A. Felix	47
5	MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site 2002 ·Oncogene ·Diana J. Slater, Eva Hilgenfeld, Eric Rappaport, Narayan R. Shah, (unknown), Wendy R. Williams, (unknown), Neil Osheroff, (unknown), Thomas Ried, Carolyn A. Felix	43
6	Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2 2001 ·British Journal of Haematology ·Eva Hilgenfeld, Hesed Padilla‐Nash, Nicole E. McNeil, Tor Knutsen, Cristina Montagna, Joëlle Tchinda, J. Horst, Wolfgang Ludwig, Hubert Serve, Thomas Büchner, Wolfgang E. Berdel, Evelin Schröck, Thomas Ried	38
7	Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms 2001 ·Genes Chromosomes and Cancer ·Hesed Padilla‐Nash, Kerstin Heselmeyer‐Haddad, Danny Wangsa, Hongen Zhang, Β. Michael Ghadimi, Merryn Macville, Meena Augustus, Evelin Schröck, Eva Hilgenfeld, (unknown)	76
8	Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma. 2001 ·PubMed ·Michael Möhr, (unknown), Eva Hilgenfeld, Elisabeth Oelmann, M. Zühlsdorf, Karsten Kratz‐Albers, (unknown), (unknown), (unknown), U. Cassens, Hubert Serve, Walter Sibrowski, Joachim Kienast, Wolfgang E. Berdel	12
9	Analysis of B-cell Neoplasias by Spectral Karyotyping (SKY) 1999 ·Current topics in microbiology and immunology ·Eva Hilgenfeld, Hesed Padilla‐Nash, Evelin Schröck, Thomas Ried	27
10	Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. 1999 ·PubMed ·Michael Möhr, Eva Hilgenfeld, Thomas Fietz, Berthold Hoppe, (unknown), Markus Hoffmann, Wolfgang Knauf, U. Cassens, Walter Sibrowski, Joachim Kienast, E. Thiel, Wolfgang E. Berdel	17
11	Ex vivo expansion of human umbilical cord blood does not lead to co-expansion of contaminating maternal mononuclear cells 1997 ·Bone Marrow Transplantation ·Thomas Fietz, Eva Hilgenfeld, W. E. Berdel, (unknown), (unknown), Wolfgang Döhle, E. Thiel, (unknown)	5
12	1248 Use of methylene blue and bicarbonate in ifosfamide-related CNS toxicity. Case report 1995 ·European Journal of Cancer ·Hubert Serve, Eva Hilgenfeld, J. Mäurer, E. Thiel, W. E. Berdel	2
13	[Diagnostic evaluation of skeletal scintigraphy in comparison to roentgen studies in histiocytosis X in childhood. Case report]. 1990 ·PubMed ·(unknown), (unknown), (unknown), Eva Hilgenfeld	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact